Clinical Trials Using Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201

There are no NCI-supported clinical trials studying adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 at this time. You can try a new search or contact our Cancer Information Service to talk about options for clinical trials.